(Nasdaq: HOLX) today announced that its Affirm ® Contrast Biopsy Software, which combines contrast-enhanced diagnostic ...

Hologic lowered its fiscal 2025 revenue forecast, citing weakness in sales of its breast health products, sending the company's shares down 5% after the bell on Wednesday. The company manufactures and ...

Explore advancements in women's health through AI, equity, and policy with Mia Keeys of Hologic on I Don’t Care.

Hologic, Inc. (NASDAQ:HOLX), a leading medical technology company specializing in women's health, diagnostics, and medical imaging systems, has been navigating a complex market landscape characterized ...

Oncologist Dr. Sarah Cate told Newsweek: "Many women simply don't make time for themselves, since they are working and often ...

according to the latest Hologic Global Women’s Health Index, one of the largest collections of data on women’s health and well-being. Hologic, Inc. (Nasdaq: HOLX), a leading women’s health ...

The Hologic Women’s Health Index‘s 2023 data found a decrease in testing for any cancer among women — a first in the survey’s four-year history. The global survey shows that, in 2023 ...

We recently published a list of 10 Firms Hit Hard in Thursday’s Trading. In this article, we are going to take a look at ...

New Mexico Educational Retirement Board cut its position in shares of Hologic, Inc. (NASDAQ:HOLX – Free Report) by 3.5% in ...

Feb 5 (Reuters) - Hologic (HOLX.O), opens new tab lowered ... medical imaging systems and surgical products focused on women's health. Ongoing saline shortage, caused by hurricane-related ...